indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Ophthalmology
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Ophthalmology
facebook x icon x icon linkedin linkedin
all-news

Rx Propellant’s 3GV Campus in Genome Valley, Hyderabad secures prestigious LEED Gold Certification

IMT News Desk

The LEED Gold certification underscores 3GV’s focus on energy efficiency, water conservation, and healthy indoor environments

Rx Propellant, an Actis Platform, has announced that its state-of-the-art life sciences campus, 3GV in Genome Valley, Hyderabad, has been awarded the LEED Gold Certification — one of the world’s most respected benchmarks for sustainable building design. The recognition highlights its commitment to creating infrastructure that not only empowers scientific progress but also sets new standards for environmental responsibility.

The LEED Gold certification underscores 3GV’s focus on energy efficiency, water conservation, and healthy indoor environments — qualities that directly benefit life sciences companies. By reducing operating costs, strengthening ESG credentials, and offering healthier workspaces, the campus provides an ecosystem where innovation and sustainability move in tandem.

This milestone builds on 3GV’s earlier achievement in 2024, when it became the world’s first IFC EDGE Advanced-certified speculative life sciences building. Together, these recognitions place 3GV at the forefront of sustainable scientific infrastructure globally, showcasing Rx Propellant’s ability to deliver pioneering campuses that meet the highest international standards.

Awarded by the US Green Building Council (USGBC), LEED (Leadership in Energy and Environmental Design) is the world’s most widely recognised green building certification. Projects are evaluated across parameters such as energy performance, water efficiency, materials selection, waste management, site sustainability, and indoor environmental quality. Achieving a Gold rating places 3GV among the top-performing buildings globally in terms of environmental impact, operational efficiency, and occupant well-being.

Praveen Kumar, Principal, Real Estate, Actis, said, “The LEED Gold certification for 3GV is a milestone that reflects our vision of building sustainable, future-ready campuses for the life sciences sector. At Actis, we believe that responsible investments must deliver long-term value to both our partners and the planet. With 3GV, we are enabling pharma and biotech companies to innovate in an environment that is energy-efficient, climate-resilient, and aligned with high global standards.”

Phani Rama Krishna, Senior Vice President – ESG, added, “From resource conservation to occupant well-being, the certification validates our efforts to minimize environmental impact while maximising operational efficiency. For life sciences companies, this means predictable costs, reduced environmental risks, and a stronger ESG profile — all of which are becoming increasingly critical in global partnerships and investor conversations.”

Shami Nissan, Partner and Managing Director, Sustainability at Actis, said, “This certification is globally significant because it demonstrates that India can combine world-class science infrastructure with sustainability at scale. Around the world, life sciences organisations are under pressure to cut carbon emissions and improve resilience, while still driving innovation at speed. 3GV shows how these goals can coexist. It sets a benchmark for how sustainable design and smart operations can empower companies to expand responsibly while contributing to a greener future.”

With this achievement, Rx Propellant continues to shape the next generation of life sciences infrastructure in India. 3GV now stands as a symbol of how sustainability and scientific excellence can go hand in hand — helping companies working there become not only future-focused but also future-proof.

Recommended

Fortis Nagarbhavi unveils next generation Mako Robotic Technology for knee joint replacements

Novo Nordisk launches Ozempic in India

Aster DM Healthcare announces Rs 120 Cr commitment for Oncology Radiation LINAC Centres

Improving breast cancer treatment in India: Early detection, empowering patients and the potential of innovation

‘Reading the mind of cancer’: Indian researchers build AI tool OncoMark to predict tumour behaviour

J&J, Asia Pacific Patient Advocacy Group leaders unite to strengthen shared decision-making in lung cancer care

Bengaluru-based Maarga Mind Care expands to Gurgaon

Johns Hopkins University collaborates with Great Learning to launch AI in healthcare prog

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions